Audiometric characteristics of a Dutch family with Muckle-Wells syndrome

Hearing Research

Volumn 282, Issue 1-2, 2011, Pages 243-251

  Weegerink, N J D ^a,b   Schraders, M ^a,b,c   Leijendeckers, J ^a,b   Slieker, K ^a   Huygen, P L M ^a   Hoefsloot, L ^a   Oostrik, J ^a,b,c   Pennings, R J E ^a,b   Simon, A ^a   Snik, A ^a,b   Kremer, H ^a,b,c   Kunst, H P M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; AUDIOMETRY; AUDITORY THRESHOLD; CHILD; CLINICAL ARTICLE; COCHLEA; CONDUCTION DEAFNESS; CONTROLLED STUDY; DUTCH; ETHNIC GROUP; FAMILY STUDY; FEMALE; FREQUENCY MODULATION; GENE; GENE MUTATION; GENETIC ANALYSIS; GROWTH CURVE; HETEROZYGOTE; HUMAN; LOUDNESS; MALE; MOLECULAR PATHOLOGY; MUCKLE WELLS SYNDROME; NLPR3 GENE; NOISE MEASUREMENT; ONSET AGE; OTOSCOPY; PATTERN RECOGNITION; PRESBYACUSIS; PRIORITY JOURNAL; SCORING SYSTEM; SPEECH ANALYSIS; SPEECH PERCEPTION;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; AUDIOMETRY, PURE-TONE; AUDIOMETRY, SPEECH; AUDITORY PERCEPTION; AUDITORY THRESHOLD; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEARING LOSS; HEREDITY; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LINEAR MODELS; LOUDNESS PERCEPTION; MALE; MIDDLE AGED; MUTATION; NETHERLANDS; NOISE; OTOSCOPY; PEDIGREE; PERCEPTUAL MASKING; PHENOTYPE; PREDICTIVE VALUE OF TESTS; REFLEX, ACOUSTIC; REFLEX, VESTIBULO-OCULAR; SPEECH PERCEPTION; VESTIBULAR FUNCTION TESTS; YOUNG ADULT;

EID: 82755182817     PISSN: 03785955     EISSN: 18785891     Source Type: Journal    
DOI: 10.1016/j.heares.2011.07.006     Document Type: Article

References (56)

1. Aganna E., Martinon F., Hawkins P.N., Ross J.B., Swan D.C., Booth D.R., Lachmann H.J., Bybee A., Gaudet R., Woo P., Feighery C., Cotter F.E., Thome M., Hitman G.A., Tschopp J., McDermott M.F. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum. 2002, 46:2445-2452.
2. Aganna E., Hawkins P.N., Ozen S., Pettersson T., Bybee A., McKee S.A., Lachmann H.J., Karenko L., Ranki A., Bakkaloglu A., Besbas N., Topaloglu R., Hoffman H.M., Hitman G.A., Woo P., McDermott M.F. Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis. Genes Immun. 2004, 5:289-293.
3. Agostini L., Martinon F., Burns K., McDermott M.F., Hawkins P.N., Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004, 20:319-325.
4. Aksentijevich I., Putnam D., Remmers E.F., Mueller J.L., Le J., Kolodner R.D., Moak Z., Chuang M., Austin F., Goldbach-Mansky R., Hoffman H.M., Kastner D.L. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007, 56:1273-1285.
5. Albrecht M., Domingues F.S., Schreiber S., Lengauer T. Structural localization of disease-associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2. FEBS Lett. 2003, 554:520-528.
6. Alves F.R., De Quintanilha Ribeiro A. Revision about hearing loss in the Alport's syndrome, analyzing the clinical, genetic and bio-molecular aspects. Braz. J. Otorhinolaryngol. 2005, 71:813-819.
7. Arostegui J.I., Aldea A., Modesto C., Rua M.J., Arguelles F., Gonzalez-Ensenat M.A., Ramos E., Rius J., Plaza S., Vives J., Yague J. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Arthritis Rheum. 2004, 50:4045-4050.
8. Biswas D., Stafford N. Otolaryngological manifestations of 'Muckle-Wells syndrome. Int. J. Pediatr. Otorhinolaryngol. 2010, 74:553-555.
9. Brydges S.D., Mueller J.L., McGeough M.D., Pena C.A., Misaghi A., Gandhi C., Putnam C.D., Boyle D.L., Firestein G.S., Horner A.A., Soroosh P., Watford W.T., O'Shea J.J., Kastner D.L., Hoffman H.M. Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity 2009, 30:875-887.
10. Cuisset L., Drenth J.P., Berthelot J.M., Meyrier A., Vaudour G., Watts R.A., Scott D.G., Nicholls A., Pavek S., Vasseur C., Beckmann J.S., Delpech M., Grateau G. Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am. J. Hum. Genet. 1999, 65:1054-1059.
11. Dalgic B., Egritas O., Sari S., Cuisset L. A variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinra. Pediatr. Nephrol. 2007, 22:1391-1394.
12. De Leenheer E.M., Huygen P.L., Coucke P.J., Admiraal R.J., Van Camp G., Cremers C.W. Longitudinal and cross-sectional phenotype analysis in a new, large Dutch DFNA2/KCNQ4 family. Ann. Otol Rhinol Laryngol. 2002, 111:267-274.
13. De Leenheer E.M., Bosman A.J., Kunst H.P., Huygen P.L., Cremers C.W. Audiological characteristics of some affected members of a Dutch DFNA13/COL11A2 family. Ann. Otol Rhinol Laryngol. 2004, 113:922-929.
14. Dode C., Le Dû N., Cuisset L., Letourneur F., Berthelot J.M., Vaudour G., Meyrier A., Watts R.A., Scott D.G., Nicholls A., Granel B., Frances C., Garcier F., Edery P., Boulinguez S., Domergues J.P., Delpech M., Grateau G. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am. J. Hum. Genet. 2002, 70:1498-1506.
15. Dode C., Cuisset L., Delpech M., Grateau G. TNFRSF1A-associated periodic syndrome (TRAPS), Muckle-Wells syndrome (MWS) and renal amyloidosis. J. Nephrol. 2003, 16:435-437.
16. Dowds T.A., Masumoto J., Zhu L., Inohara N., Nunez G. Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J. Biol. Chem. 2004, 279:21924-21928.
17. Feldmann J., Prieur A.M., Quartier P., Berquin P., Certain S., Cortis E., Teillac-Hamel D., Fischer A., De Saint Basile G. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am. J. Hum. Genet. 2002, 71:198-203.
18. Frenkel J., Van Kempen M.J., Kuis W., Van Amstel H.K. Variant chronic infantile neurologic, cutaneous, articular syndrome due to a mutation within the leucine-rich repeat domain of CIAS1. Arthritis Rheum. 2004, 50:2719-2720.
19. Gattorno M., Tassi S., Carta S., Delfino L., Ferlito F., Pelagatti M.A., D'Osualdo A., Buoncompagni A., Alpigiani M.G., Alessio M., Martini A., Rubartelli A. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum. 2007, 56:3138-3148.
20. Hawkins P.N., Lachmann H.J., McDermott M.F. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N. Engl. J. Med. 2003, 348:2583-2584.
21. Hawkins P.N., Lachmann H.J., Aganna E., McDermott M.F. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum. 2004, 50:607-612.
22. Hentgen V., Despert V., Lepretre A.C., Cuisset L., Chevrant-Breton J., Jego P., Chales G., Gall E.L., Delpech M., Grateau G. Intrafamilial variable phenotypic expression of a CIAS1 mutation: from Muckle-Wells to chronic infantile neurological cutaneous and articular syndrome. J. Rheumatol. 2005, 32:747-751.
23. Hoffman H.M., Mueller J.L., Broide D.H., Wanderer A.A., Kolodner R.D. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 2001, 29:301-305.
24. Huygen P.L.M., Pennings R.J.E., Cremers C.W.R.J. Characterising and distinguishing progressive phenotypes in nonsyndromic autosomal dominant hearing impairment. Audiological Med. 2003, 1:37-46.
25. Aucoustics: Threshold of hearing by air conduction as a function of age and sex for otologically normal persons 1984, International Organization for Standardization. ISO 7029, Geneva, Switzerland.
26. Jeru I., Hayrapetyan H., Duquesnoy P., Sarkisian T., Amselem S. PYPAF1 nonsense mutation in a patient with an unusual autoinflammatory syndrome: role of PYPAF1 in inflammation. Arthritis Rheum. 2006, 54:508-514.
27. Jeru I., Marlin S., Le Borgne G., Cochet E., Normand S., Duquesnoy P., Dastot-Le Moal F., Cuisset L., Hentgen V., Fernandes Alnemri T., Lecron J.C., Dhote R., Grateau G., Alnemri E.S., Amselem S. Functional consequences of a germline mutation in the leucine-rich repeat domain of NLRP3 identified in an atypical autoinflammatory disorder. Arthritis Rheum. 2010, 62:1176-1185.
28. Koike R., Kubota T., Hara Y., Ito S., Suzuki K., Yanagisawa K., Uchibori K., Miyasaka N. A case of Muckle-Wells syndrome caused by a novel H312P mutation in NALP3 (cryopyrin). Mod. Rheumatol. 2007, 17:496-499.
29. Kuemmerle-Deschner J.B., Tyrrell P.N., Koetter I., Wittowski H., Bialkowski A., Tzaribachev N., Lohse P., Koitchev A., Deuter C., Foell D., Benseler S.M. Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome (2011). Arthritis Rheum. 2010, 63:840-849.
30. Kummerle-Deschner J.B., Tyrrell P.N., Reess F., Kotter I., Lohse P., Girschick H., Huemer C., Horneff G., Haas J.P., Koitschev A., Deuter C., Benseler S.M. Risk factors for severe Muckle-Wells syndrome. Arthritis Rheum. 2010, 62:3783-3791.
31. Latz E. The inflammasomes: mechanisms of activation and function. Curr. Opin. Immunol. 2010, 22:28-33.
32. Legent F., Prost A., Beauvillain C., Wallez B., Gallois J.R. Deafness in the Muckle-Wells syndrome. Ann. Otolaryngol. Chir Cervicofac 1976, 93:355-365.
33. Leslie K.S., Lachmann H.J., Bruning E., McGrath J.A., Bybee A., Gallimore J.R., Roberts P.F., Woo P., Grattan E.C., Hawkins P.N. Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations. Arch. Dermatol. 2006, 142:1591-1597.
34. Maksimovic L., Stirnemann J., Caux F., Ravet N., Rouaghe S., Cuisset L., Letellier E., Grateau G., Morin A.S., Fain O. New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes. Rheumatology (Oxford) 2008, 47:309-310.
35. Manji G.A., Wang L., Geddes B.J., Brown M., Merriam S., Al-Garawi A., Mak S., Lora J.M., Briskin M., Jurman M., Cao J., DiStefano P.S., Bertin J. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B. J. Biol. Chem. 2002, 277:11570-11575.
36. Marres H., Van Ewijk M., Huygen P., Kunst H., Van Camp G., Coucke P., Willems P., Cremers C. Inherited nonsyndromic hearing loss. An audiovestibular study in a large family with autosomal dominant progressive hearing loss related to DFNA2. Arch. Otolaryngol. Head Neck Surg. 1997, 123:573-577.
37. Matsushima N., Tachi N., Kuroki Y., Enkhbayar P., Osaki M., Kamiya M., Kretsinger R.H. Structural analysis of leucine-rich-repeat variants in proteins associated with human diseases. Cell Mol. Life Sci. 2005, 62:2771-2791.
38. McDermott M.F., Aganna E., Hitman G.A., Ogunkolade B.W., Booth D.R., Hawkins P.N. An autosomal dominant periodic fever associated with AA amyloidosis in a north Indian family maps to distal chromosome 1q. Arthritis Rheum. 2000, 43:2034-2040.
39. Meng G., Strober W. New insights into the nature of autoinflammatory diseases from mice with Nlrp3 mutations. Eur. J. Immunol. 2010, 40:649-653.
40. Meng G., Zhang F., Fuss I., Kitani A., Strober W. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 2009, 30:860-874.
41. Merchant S.N., Burgess B.J., Adams J.C., Kashtan C.E., Gregory M.C., Santi P.A., Colvin R., Collins B., Nadol J.B. Temporal bone histopathology in alport syndrome. Laryngoscope 2004, 114:1609-1618.
42. Mirault T., Launay D., Cuisset L., Hachulla E., Lambert M., Queyrel V., Quemeneur T., Morell-Dubois S., Hatron P.Y. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Arthritis Rheum. 2006, 54:1697-1700.
43. Montealegre Sanchez G.A., Hashkes P.J. Neurological manifestations of the Mendelian-inherited autoinflammatory syndromes. Dev. Med. Child. Neurol. 2009, 51:420-428.
44. Moon I.S., Bang M.Y., Shim D.B., Shin S.H., Choi J.Y. Severe to profound hearing loss in patients with progressed Alport's syndrome. Acta Otolaryngol. 2008, 129:982-987.
45. Moser L.M. The Wurzburg auditory field, a test for prosthetic audiometry. HNO 1987, 35:318-321.
46. Muckle T.J., Wells M. Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q. J. Med. 1962, 31:235-248.
47. Neven B., Callebaut I., Prieur A.M., Feldmann J., Bodemer C., Lepore L., Derfalvi B., Benjaponpitak S., Vesely R., Sauvain M.J., Oertle S., Allen R., Morgan G., Borkhardt A., Hill C., Gardner-Medwin J., Fischer A., De Saint Basile G. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 2004, 103:2809-2815.
48. O'Connor W., Harton J.A., Zhu X., Linhoff M.W., Ting J.P. Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties. J. Immunol. 2003, 171:6329-6333.
49. Plantinga R.F., Cremers C.W., Huygen P.L., Kunst H.P., Bosman A.J. Audiological evaluation of affected members from a Dutch DFNA8/12 (TECTA) family. J. Assoc. Res. Otolaryngol. 2007, 8:1-7.
50. Plomp R., Mimpen A.M. Improving the reliability of testing the speech reception threshold for sentences. Audiology 1979, 18:43-52.
51. Rynne M., Maclean C., Bybee A., McDermott M.F., Emery P. Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism. Ann. Rheum. Dis. 2006, 65:533-534.
52. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
53. Smoorenburg G.F. Speech reception in quiet and in noisy conditions by individuals with noise-induced hearing loss in relation to their tone audiogram. J. Acoust. Soc. Am. 1992, 91:421-437.
54. Sutterwala F.S., Ogura Y., Szczepanik M., Lara-Tejero M., Lichtenberger G.S., Grant E.P., Bertin J., Coyle A.J., Galan J.E., Askenase P.W., Flavell R.A. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006, 24:317-327.
55. Van der Hilst J.C., Simon A., Drenth J.P. Hereditary periodic fever and reactive amyloidosis. Clin. Exp. Med. 2005, 5:87-98.
56. Yamazaki T., Masumoto J., Agematsu K., Sawai N., Kobayashi S., Shigemura T., Yasui K., Koike K. Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome. Arthritis Rheum. 2008, 58:864-868.